^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
ADU-1805
i
Other names: ADU-1805, ADU 1805
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Exelixis, Sairopa
Drug class:
SIRPA antagonist
Related drugs:
12ms
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors (clinicaltrials.gov)
P1, N=90, Recruiting, Sairopa B.V. | Not yet recruiting --> Recruiting
Enrollment open • Metastases
|
Keytruda (pembrolizumab) • ADU-1805
1year
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors (clinicaltrials.gov)
P1, N=90, Not yet recruiting, Sairopa B.V.
New P1 trial • Metastases
|
Keytruda (pembrolizumab) • ADU-1805
Share via
